Abstract

Induced pluripotent stem cell (iPSC) reprogramming is inefficient and understanding the molecular mechanisms underlying this inefficiency holds the key to successfully control cellular identity. Here, we report 24 reprogramming roadblock genes identified by CRISPR/Cas9-mediated genome-wide knockout (KO) screening. Of these, depletion of the predicted KRAB zinc finger protein (KRAB-ZFP) Zfp266 strongly and consistently enhances murine iPSC generation in several reprogramming settings, emerging as the most robust roadblock. We show that ZFP266 binds Short Interspersed Nuclear Elements (SINEs) adjacent to binding sites of pioneering factors, OCT4 (POU5F1), SOX2, and KLF4, and impedes chromatin opening. Replacing the KRAB co-suppressor with co-activator domains converts ZFP266 from an inhibitor to a potent facilitator of iPSC reprogramming. We propose that the SINE-KRAB-ZFP interaction is a critical regulator of chromatin accessibility at regulatory elements required for efficient cellular identity changes. In addition, this work serves as a resource to further illuminate molecular mechanisms hindering reprogramming.

Induced pluripotent stem cell (iPSC) reprogramming is inherently inefficient. Here the authors identify 24 reprogramming roadblock genes through a CRISPR/Cas9-mediated genome-wide knockout screen including a KRAB-ZFP Zfp266, knockout of which consistently enhances murine iPSC generation.

Details

Title
B1 SINE-binding ZFP266 impedes mouse iPSC generation through suppression of chromatin opening mediated by reprogramming factors
Author
Kaemena, Daniel F. 1 ; Yoshihara, Masahito 2   VIAFID ORCID Logo  ; Beniazza, Meryam 1 ; Ashmore, James 1 ; Zhao, Suling 1 ; Bertenstam, Mårten 3 ; Olariu, Victor 3 ; Katayama, Shintaro 4   VIAFID ORCID Logo  ; Okita, Keisuke 5   VIAFID ORCID Logo  ; Tomlinson, Simon R. 1 ; Yusa, Kosuke 6   VIAFID ORCID Logo  ; Kaji, Keisuke 1   VIAFID ORCID Logo 

 University of Edinburgh, Centre for Regenerative Medicine, Institute for Regenaration and Repair, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Chiba University, Institute for Advanced Academic Research, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101); Chiba University, Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba, Japan (GRID:grid.136304.3) (ISNI:0000 0004 0370 1101) 
 Lund University, Computational Biology and Biological Physics, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
 Karolinska Institutet, Department of Biosciences and Nutrition, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); University of Helsinki, Research Programs Unit, Stem Cells and Metabolism Research Program (STEMM), Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Folkhälsan Research Center, Helsinki, Finland (GRID:grid.428673.c) (ISNI:0000 0004 0409 6302) 
 Kyoto University, Center for iPS Cell Research and Application, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033) 
 Wellcome Sanger Institute, Stem Cell Genetics, Cambridge, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382); Kyoto University, Stem Cell Genetics, Institute for Life and Medical Sciences, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033) 
Pages
488
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2770823596
Copyright
© Crown 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.